# Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons

> **NCT02572323** · PHASE2 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 73 (actual)

## Conditions studied

- Mild Cognitive Impairment

## Interventions

- **DRUG:** Tesamorelin

## Key facts

- **NCT ID:** NCT02572323
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-15
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-10-15
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2026-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572323, "Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02572323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*